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This paper will review the basics of neurostimulation in the perioperative
period. Following a brief overview of neuromuscular physiology, the mecha-
nism of action of depolarizing and non-depolarizing relaxants will be dis-
cussed. The principles ofneurostimulation will then be applied clinically when
different patterns ofstimulation (single twitch, train-of-four, post-tetanic twitch
count, double burst) are described. Clinical assessment ofneuromuscular func-
tion will then be compared with both subjective and objective means of assess-
ment of adequacy of intraoperative relaxation and postoperative reversal. The
principles reviewed in this paper will then be applied in the clinical setting, and
risks and benefits associated with perioperative use ofmuscle relaxants will be
discussed.
Muscle relaxants have been used in clinical anesthesia ever since Griffith and
Johnson reported that "curare may prove to be a drug which will occasionally be ofgreat
value" [1]. The intervening period has taught us the usefulness of muscle relaxants, and
that the response to these agents varies widely between individuals [2, 3]. The response
may be further altered by certain disease states, electrolyte imbalances and/or drug inter-
actions [4, 5, 6,7, 8].
To minimize patient morbidity and optimize use ofoperating room time, monitoring
of neuromuscular blockade is essential during the perioperative period. Clinical assess-
mentofneuromuscular function and use ofnerve stimulators are the mostcommon moni-
toring methods, but despite their use, residual curarization occurs with various relaxant
regimens [9, 10, 11, 12, 13, 14]. An understanding of the techniques used to monitor
neuromuscular function, coupled with knowledge ofthe relevant physiology and pharma-
cology, will enable anesthesiologists to pursue ourgoal ofoptimalpatientcare.
NEUROMUSCULAR PHYSIOLOGY
Skeletal muscle fibers are innervated by motor neurons, whose cell bodies lie in the
anterior horn of the spinal cord or in the corresponding motor nuclei of cranial nerves.
These somatic motor neurons are typically thick, myelinated, fast conducting fibers. As
the axon approaches its termination, it loses its myelin sheath and divides into a number
ofterminal branches. Each neural branch supplies a single muscle fiber, via the interven-
ing neuromuscularjunction.
At the neuromuscularjunction, the membrane ofthe muscle fiber is thickened and is
known as the motor end plate. The terminal nerve filaments are swollen and fit into
depressions in the motor end plate. The narrow space between the nerve terminal and the
aTo whomallcorrespondence shouldbe addressed. Tel. (203) 785-2802; FAX: (203) 785-6664.
bAbbreviations used: ACh, acetylcholine; EPP, end-plate potential; NMJ, neuromuscularjunction;
TOF, train-of-four; DBS, double burst stimulation; EMG, electromyography; PTP, post-tetanic
potentiation.
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muscle membrane is analogous to the synaptic cleft between neurons. The entire region
of the neuromuscular junction is enclosed by Schwann cells which separate it from the
surrounding extracellular fluid [15].
The nerve terminal synthesizes AChb and stores it in vesicles [16]. When the nerve
is stimulated, its action potential travels downwards and opens Ca++ channels in the
nerve terminal membrane [17]. The inward movement of Ca++ triggers fusion of the
synaptic vesicles with the nerve membrane (exocytosis) and ACh is released into the
synaptic cleft. ACh is released in standardamounts, known as quanta.
The ACh diffuses across the synaptic cleft to the nicotinic ACh receptors on the
membrane of the muscle end plate. The ACh receptor straddles the muscle membrane
and consists of 5 subunits (2 alpha, 1 beta, 1 delta and 1 epsilon) arranged as in a cylin-
der around a central channel [18]. When both alpha subunits are occupied by ACh
molecules (or a depolarizing relaxant), the channel opens. This is an "all or none"
response. Nae and Ca++ ions enter the muscle cell, and K+ ions exit through the open
channel. The resultant ion flux generates an EPP'. Individual EPPs may summate and
once the local potential depolarizes the adjacentmuscle membrane to its firing threshold,
a muscle action potential is generated. The muscle action potential (an all-or-none
response) is conducted along the muscle fiber. Subthreshold stimuli are not propagated
along the muscle fiber, but do cause a localized depolarizing potential, which either sum-
mates with otherEPPs (eventually reaching threshold), orgradually decays with time.
The post-synaptic end plate contains approximately 5 million ACh receptors [19].
When 5-10% of these are open, the EPP typically reaches threshold and a muscle action
potential is produced [20]. Each ACh vesicle contains about 10,000 ACh molecules, and
a nerve impulse typically releases 50-60 ACh vesicles [21]. This amount of neurotrans-
mitter is sufficient to activate about 10 times the number of the ACh receptors required
toproduce a muscle action potential [21].
A single muscle action potential causes a briefcontraction of the fiber (known as a
muscle twitch), followed by relaxation. The depolarization of the muscle membrane is
transmitted to all the fibrils in the muscle fiber by a collection of tubules (T system) and
triggers release ofCa++ from the sarcoplasmic reticulum [22]. The Ca++ release initiates
interaction of the actin and myosin filaments, and results in contraction of the muscle
[22]. The complete process by which depolarization of the muscle membrane initiates
contraction is known as excitation-contraction coupling. The depolarization of the mem-
brane and the mechanical process which results are separateentities.
MECHANISM OF ACTION OFMUSCLE RELAXANTS
The muscle relaxants used in clinical anesthesia may be classified into two groups,
depolarizing and non-depolarizing. Curare is the prototype of the non-depolarizing
group, which includes atracurium, vecuronium, and pancuronium amongst others. These
agents bind to the alpha subunit ofthe post-synaptic nicotinic receptor andcompetitively
block the transmitter action of ACh. By increasing the concentration of these competi-
tive antagonists at the synaptic cleft, the amplitude of the EPP is progressively dimin-
ished. The EPP may have to fall below 70% ofits initial value before it is insufficient to
initiate a muscle action potential, which provides a safety factor in neuromuscular trans-
mission [23]. Binding oftwo agonist molecules, one on each alpha subunit, is needed for
receptor activation, whereas binding of one antagonist molecule to the receptor is suffi-
cient to render it non-functional [24, 25]. In addition, pre-synaptic binding ofnon-depo-
larizing relaxants may oppose mobilization and release ofACh [26, 27]. During a non-
depolarizing block the musclecontinues to respond todirectelectrical stimulation.
Depolarizing relaxants, such as succinylcholine and decamethonium, initially depo-
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larize the membrane by opening receptor channels, in a similar manner as ACh. However,
they persist at the NMJ and result in prolonged end-plate depolarization [23]. This brief
period of repetitive excitation is manifested by transient muscle fasciculations, followed
by blockade of neuromuscular transmission and flaccid paralysis. Prolonged stimulation
of the receptor by ACh will produce a similar response.
At the perimeter of the muscle end-plate, a grouping of Nae channels is responsible
for propagation of the action potential [28]. Each Nae channel consists of two "gates." In
resting muscle, the lower (time-dependent) gate is open, while the upper (voltage depen-
dent) gate is closed [20, 29]. Depolarization of the end-plate opens the upper gate, allow-
ing ion exchange and propagation of the muscle action potential. Soon after the upper
gate opens, the lower gate closes, thereby terminating the ion exchange. The lower gate
remains closed until the uppergate shuts, and the cell returns to its resting state. However,
the persistent end-plate depolarization produced by succinylcholine is maintained until
the lower gate closes, thereby preventing further action potential propagation beyond the
junctional rim. Thus, after an initial period of muscle fasciculations, flaccid paralysis
results [23].
The nicotinic receptor may also be inactivated by channel block, which involves
interference with the transfer of ions through the transmembrane channels. Open channel
block and closed channel block are the two principal types [30, 31]. The latter involves
direct occlusion of the channel mouth, independent of channel opening. Ion transfer is
prevented and end-plate depolarization fails to occur [30, 32]. In open channel block,
after the channel has been opened by an agonist, amolecule enters and occludes the chan-
nel thereby preventing end-plate depolarization. The intensity of open channel block
varies with the frequency of channel activation, as only open channels can be affected.
The potential across the end plate draws the molecule, which is usually charged, into the
channel. The receptor is tunnel shaped and the molecule is unable to traverse its narrow
portion. The duration of the block varies with the size and shape of the molecule: some
leave the channel quickly, whereas others bind to it and produce a longer lasting effect
[33]. Open channel block does not occur at the ACh binding site, and so this process is
notcompetitive antagonism [19, 30, 32, 34].
Desensitization may also inactivate the nicotinic receptors; this occurs when the
receptors bind agonists in the normal fashion, but the receptors do not undergo the struc-
tural changes that normally open the channel. Desensitization involves a conformational
change in the structure of the receptor [33]. Receptor proteins are constantly changing
between theresting and desensitized states, and someagonists may promote the transition
to the desensitized state [33].
During prolonged exposure to a depolarizing relaxant, the typical (phase 1) block
may assume the characteristics of a non-depolarizing (phase 2) block. Persistent binding
of depolarizing agents to the alpha subunits of the receptor induces desensitization [33,
35, 36]. This is thought to be the mechanism responsible forphase 2 block, but other fac-
tors may contribute (e.g., abnormal transmembrane electrolyte balance). In addition,
many agents that enhance neuromuscular blockade also promote desensitization of the
nicotinic receptor and/or cause channel block (e.g., barbiturates, volatile anesthetics, local
anesthetics, andcholinesterase inhibitors) [20, 37, 39].
PRINCIPLES OF NERVE STIMULATION
The nerve stimulator generates an electric current which is delivered to a nerve fiber
via surface or subcutaneous (needle) electrodes. The aim of the stimulator is to induce
equal degrees of nerve depolarization over time. This is best achieved by using a supra-
maximal current which stimulates all fibers in the nerve bundle. Using surface electrodes,
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a current of 30-50 mA is typically needed to ensure supramaximal stimulation, while
using subcutaneous electrodes this value is typically around 10 mA. Production of a neu-
ral action potential depends on the current applied by the stimulator, and not the voltage.
Ohm's Law states that the amount ofcurrent (I) that flows through a body is equal to the
driving voltage (V) divided by the electrical resistance (R). Thus, any change in skin
impedance requires a proportional change in the applied voltage to ensure a constant cur-
rent, and hence a constant level of nerve depolarization. Ideally, the stimulator should
have a current display unit which alerts the operator when the current selected is not
being delivered, orelse the degree ofblockade may be misjudged.
Skin resistance is reduced by applying a conducting solution (usually silver/silver
chloride gel) to clean, dry skin. The impedance may change intraoperatively due to dry-
ing of electrolyte gel, cooling of skin or displacement ofelectrodes. Therefore, constant-
voltage stimulators have been replaced by constant-current ones, thus ensuring consisten-
cy ofresponse. A constant current can be delivered more effectively via needle electrodes
placed subcutaneously. The electrodes are in close proximity to the nerve and more likely
to stimulate all the neural fibers, being less affected by physical factors such as obesity
and increased skin impedance.
Other important features of the electrical pulse delivered by the stimulator are the
wave form and its duration. The stimulus should be monophasic (i.e., square wave)
because biphasic waves may result in repetitive nerve firing. The intensity ofthe stimulus
(in milliamperes, mA) required to initiate nerve firing increases exponentially as the
pulse duration decreases: a short impulse requires a higher current to cause the nerve to
fire. However, if the pulse width exceeds 0.5 msec, direct muscle stimulation orrepetitive
neural firing may result. In addition, the amplitude of the evoked response shows little
change with pulse durations exceeding 0.1 msec if the current intensity is kept constant.
In clinical practice, pulse widths of 0.1-0.3 msec are usually employed, as this range is
optimal for assessment ofdepth ofneuromuscular block.
The rate ofstimulus application to the nerve also influences the evoked response. At
the unblocked NMJ, supraphysiological stimulation rates (e.g., above 70-200 Hz) will
cause fatigue in the muscle [40, 41]. This fatigue is due to inability to mobilize sufflcient
ACh at the presynaptic nerve terminal to sustain the high frequency response. A brief
tetanic stimulation at 50-100 Hz, in the setting of normal neuromuscular transmission,
results in a sustained contraction without fade. In the presence of a non-depolarizing
block, fatigue (i.e., fade) is noted at slower stimulation rates. This characteristic is uti-
lized in the train-of-four and tetanic stimulation (see below) to estimate the extent ofneu-
romuscular block [42,43].
In addition to inducing fatigue, frequent stimulation increases local blood flow, thus
speeding delivery ofrelaxant to the stimulated muscle [44, 45, 46]. In the clinical setting,
the frequency of neurostimulation and the rate ofonset ofdepolarizing and non-depolar-
izing block are directly proportional, such that an increase in stimulation frequency will
result in a falsely elevated rate ofonset [46, 47, 48, 49, 50]. Both these effects (induction
offatigue and increase in blood flow) can reduce the apparentdose requirements for mus-
cle relaxants [47].
PATTERNS OF NERVE STIMULATION
The extent of neuromuscular blockade may be assessed by several different patterns
ofstimulation. These include single twitch, train-of-four, double burst, and tetanic stimu-
lation, and post-tetanic twitch count (Table 1).
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Table 1. Features ofdifferent patterns ofneurostimulation.
Features
*A supramaximal stimulus delivered at 0.1 to 1.0 Hz.
-Rate ofstimulus delivery affects muscle response.
-Baseline twitchheightrequired; subsequent accuracy may be impaired.
-Narrow range ofreceptor block detection (75-95%).
*Does notdifferentiate depolarizing & non-depolarizing block.
*Four supramaximal stimuli at 2 Hz.
-Less painful than tetanic stimulation and may be used in awake patients
(ICU).
*Differentiates depolarizing & non-depolarizing block.
-Useful for detection ofblock in the range ofsurgical relaxation (70-
100% receptor occupancy).
*Does not induce potentiation ofsubsequent responses or recovery.
*No baseline (pre-relaxant) response needed.
*Two short tetanic bursts (2 or 3 impulses at 50 Hz) separated by 750
msec.
-Clinical assessment (tactile & visual) ofDBS superior to TOF in detect-
ing fade.
*No control baseline necessary.
-May induce potentiation ofsubsequent responses.
-Painful to awake patients.
-Typically 50 Hz for 5 sec
-Differentiates depolarizing & non-depolarizing block.
*May induce direct muscle stimulation.
-Painful; therefore less useful in awakepatients.
-Enhances subsequent neuromuscular responses and recovery.
-Degree offade varies with frequency and duration ofapplied
stimulus.
Post-Tetanic Count -Tetanus (50 Hz for 5 sec) followed 3 sec laterby single supramaximal
stimuli at 1 Hz.
-Allows profound degrees ofblock to be assessed.
-Useful to ensure "complete" block.
-Accuracy ofPTC depends on many variables (eg. duration & frequency
oftetanic stimulation, latency period between tetanus & single stimuli,
frequency ofsingle twitches, etc)
*Frequent tetanic stimuli may antagonize the apparentneuromuscular
block.
Single twitch
With this mode, a supramaximal stimulus is applied to the nerve prior to the adminis-
tration of muscle relaxant and a baseline amplitude of the muscle twitch is established.
The degree ofblock produced by the relaxant can be estimated by comparing any subse-
quent twitch height to that of the baseline. The frequency of the applied stimulus affects
the response of the muscle to single twitch stimulation (see above). Changing the stimu-
lus frequency from 0.1 Hz to 1.0 Hz can decrease the ED95 of d-tubocurarine (the effec-
tive dose for 95% twitch depression of the thumb adduction) by a factor of 3 or more
[47]. A supramaximal stimulus lasting 0.2 msec with a frequency of 0.1 Hz is the com-
monest single twitch technique. However, a frequency between 0.1 and 1.0 Hz may be
selected.
The response to single twitch stimulation disappears completely once 90-95% of the
Pattern
SingleTwitch
Train-of-Four
Double Burst
Stimulation
Tetanus
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receptors are blocked, but the response is not reduced until 75-80% of the receptors are
occupied. Thus, the range of receptor blockade detected by single twitch stimulus (i.e.,
approximately 75-95%) is narrow [51], limiting its clinical usefulness.
Other factors limiting the clinical usefulness of single twitch include its sensitivity
to variations in current, skin temperature, and resting muscle tension (preload). In addi-
tion, careful documentation ofbaseline twitch height is needed for comparison with sub-
sequent twitches. When the control height is evaluated visually orby palpation (as often
occurs in clinical practice), subsequent responses are difficult to assess and compare
accurately.
Train-offour
In the train-of-four (TOF) pattern, four supramaximal stimuli are applied at a fre-
quency of2 Hz. In the presence ofa non-depolarizing block, this frequency is associated
with clearly separated muscle responses which exhibitfade. Thedegreeoffade is propor-
tional to the extent of the neuromuscular block. Thus, the ratio of the amplitude of the
fourth response (T4) to that of the first response (T7) estimates the extentofnon-depolar-
izing block. This ratio isknown as theT4/T1 ratioorTOFratio.
At the unblocked NMJ, the T4iT1 ratio approximates 1.0. During a partial depolariz-
ing block, the twitch height is reduced to the same extent in all four responses, and no
fade is induced, theT4/Tj ratio approximating 1.0. If a phase 2 block develops after suc-
cinylcholine administration, the TOFresponse will show "fade", as thedepolarizing agent
exhibits features ofa competitive blocker. During apartial non-depolarizing block, the T4
amplitude starts to decrease when 70-75% ofthe receptors are occupied. TheT1 response
may not decline until theT4/Tj ratio fallsbelow 0.7.
When the T4 response is lost completely, approximately 80% of the receptors are
blocked. Disappearance of the T3 and T2 responses corresponds to 85% and 85-90%
receptor occupancy, respectively [52]. When 90-95% of the receptors are blocked, T1
disappears, its amplitude having decreased progressively with increasing receptor occu-
pancy [51, 52].
Since its introduction in the 1970's [53], TOFstimulation has become the most popu-
lar method of assessing neuromuscular block in clinical practice. It is considerably less
painful than tetanic stimulation and may be used in awake patients to detect residual
block. Once the T4 and T1 responses are detectable, the TOF ratio is consistent at sub-
maximal and supramaximal intensities [54, 55]. This makes TOF more comfortable for
awake patients, as the pain experienced is directly related to the intensity ofthe stimulat-
ing current [56].
TOFdoes result in fadeduring apartial non-depolarizing block but, unlike tetanus, it
does not facilitate subsequent neuromuscular responses [42,43, 57]. Thus, TOFdoes not
induce changes in subsequent recovery. It also does not require a preoperative control
height, as the degree ofblock is proportional to the T4/1T ratio [52, 58, 59]. AT4/T1 ratio
of 0.75 generally correlates with a sustained muscle response to 50 Hz (for 5 sec) and
with a single twitch height which has returned to baseline. This degree ofblock also cor-
relates with clinically adequate neuromuscular function, although a greater degree of
recovery may be necessary in somepatients.
Tetanicstimulation
In the normal individual, high frequency neurostimulation (30-100 Hz) results in
repetitive muscle action potentials and a sustained muscle contraction [40]. Initially, large
quantities ofACh are released from preformed vesicles in the nerveendings. As the stim-
ulus persists, the rate of ACh release decreases. Normally, greater quantities of ACh are
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released from pre-synaptic stores than are necessary; therefore, muscle depolarization in
response to tetanic stimulation persists despite decreasing ACh release, and muscle con-
traction is sustained. In clinical practice, a stimulus of 50 Hz for 5 sec is usually selected,
as the muscle tension evoked approximates that achieved during maximal voluntary effort
[40].
During a pure depolarizing block, the peak muscle tension is reduced, but it is sus-
tained for the 5-sec duration. With non-depolarizing (and phase 2) block, the peak tension
is reduced and "fades" with sustained stimulus [53, 60]. The degree of fade depends pri-
marily on the extent of the neuromuscular block and, thus, may be used to quantify the
block. Fade also varies proportionately with the frequency of the applied stimulus, being
greater at higher frequencies. In addition, the longer the duration of the tetanic stimulus,
the greater the extent of fade. Recent studies suggest that the degree offade is not signifi-
cantly altered by apreceding tetanic stimulus given as recently as 2 min earlier [61].
Tetanic fade is generally thought to be a pre-synaptic phenomenon, though contro-
versy exists as to its exact nature. One explanation is that the competitive block of the
relaxant at the post-synaptic receptor narrows the safety margin and that, despite repeti-
tive stimulation, the nerve terminal is unable to mobilize ACh quickly enough to over-
come the block [62]. Competitive antagonism of pre-synaptic cholinergic receptors with
alteration in Ca++ fluxes in the nerve terminal also may play a role by altering ACh mobi-
lization [20]. Moreover, open-channel block has been proposed as an alternative mecha-
nism, in which the antagonist may physically block the open postsynaptic channels [34].
In the presence of a non-depolarizing or phase 2 block tetanic stimulation may result
in an enhanced subsequent neuromuscular response (i.e., the evoked twitch tension is
increased). This effect usually occurs ifthe stimulus is applied within 60-120 sec follow-
ing the tetanic stimulus. The duration and magnitude of this PTP is a function of the
degree of neuromuscular block [63] and may result in underestimation of the degree of
block if evoked responses are assessed during the period of potentiation. The muscle
block induced by succinylcholine does not exhibit PTP.
Thus, tetanic stimulation shortens the time to recovery of neuromuscular transmis-
sion as measured by TOF and double burst stimulation (DBS, see below), such that the
evoked response ofthe tested site may no longer be representative ofother muscle groups
[63, 64]. Since tetanic stimulation is painful, it should be applied to anesthetized patients
only, thus limiting its usefulness in settings in which patients are awake (i.e., intensive
care orpostanesthesia care units).
Post tetanic twitch count
When the non-depolarizing blockade is profound, TOF or single twitch stimulation
evoke no response and cannot quantify the extent ofthe block. However, the potentiation
of neuromuscular transmission that occurs after tetanic stimulation may enable single
stimuli to produce a response [65, 66]. PTC method takes advantage of this period of
enhanced evoked responses to assess the duration until return ofneuromuscular function
even when single-twitch, TOF or DBS evoke no response. PTC is generally used to
ensure profound muscle block, such as during microsurgery, ophthalmic surgery, and
when "bucking" on the endotracheal tube could have disastrous consequences [67]. A
tetanic stimulus (50 Hz for 5 sec) is delivered, and 3 sec later, single supramaximal stim-
uli are delivered once every second (i.e., at 1 Hz). The number of twitches elicited is
inversely proportional to the degree of block, and is known as the post tetanic twitch
count [65].
For each non-depolarizing relaxant, the first response to the TOF stimulation typi-
cally occurs when the post tetanic twitch count has reached a certain value. The PTC,
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therefore, allows the time to recovery of a profound block to be estimated and allows
reversal with anticholinesterases to be planned.
While the PTC depends primarily on the degree of neuromuscular block, it varies
with other factors which must be controlled, in order for PTC to be clinically useful.
Thus, the frequency and duration of the tetanic stimulus, the time interval between the
tetanic stimulus and the first twitch stimulus and the frequency ofthe single twitch stim-
uli all must be standardized. In addition, as noted above, repetitive tetanic stimulation
may antagonize the neuromuscular block such that the blocked muscle is not truly repre-
sentative of the extent of the block at other muscle groups. Thus, the tetanic stimulus
should notbeapplied any more frequently than once every 3 or4 min [68].
Double burst stimulation
DBS was introduced in the late 1980's as an alternative method ofmonitoring neuro-
muscular blockade [69, 70, 71]. It involves two short bursts of50-Hz tetanic stimuli sep-
arated by 750 msec. While the duration ofeach individual twitch is 0.2 msec, the number
ofimpulses in each ofthe two bursts may vary; thepattern using 3 impulses in each burst
(DBS3,3) has gained widest use in clinical practice. When DBS3,3 is applied to the
unblocked NMJ, two short muscle contractions ofequal strength are induced. In the par-
tially blocked patient, DBS3,3 results in a weaker second response (i.e., the response
fades), the degree of fade being proportional to the extent of the neuromuscular block.
DBS and TOF correlate closely over a wide range ofblock and stimulating currents [70,
71, 72].
When the TOF response is evaluated by visual and tactile means, minor degrees of
neuromuscular block cannot be excluded with certainty [73]. The main advantage of
DBS in clinical practice is that fade ofDBS-evoked responses may be easier to evaluate
by subjective means than with TOF [72].
THE NERVE STIMULATOR AND ELECTRODES
As mentioned previously, the nerve stimulator should provide a constant current
stimulus as opposed to a constant voltage. The wave form should be monophasic, and its
duration should not exceed 0.5 msec. Supramaximal stimulation ofthe nerve is desirable
when assessing single twitch responses and, thus, the stimulator should be capable of
delivering a current of60-70 mA. A current display unit should ideally be incorporated,
and the selected current should be maintained for the duration of the impulse. Multiple
patterns of stimulation (single twitch, train-of-four, double burst, tetanic, post-tetanic
twitch count) should be possible. For safety purposes, the stimulator should be battery-
operated, it should include a means to test the battery, and should be enclosed in a plastic
case. During use, the stimulator should be placed on a non-conductive surface, and its
electrodes should always be regarded as a potential route for unintentional electrocautery
grounding. The polarity ofthe electrodes shouldbe clearly indicated. Other desirable fea-
tures include an audible signal with each stimulus delivered and the ability to calculate
and display fade ratio and/or percentdepression ofsingle twitch amplitude frombaseline.
Skin or subcutaneous electrodes may be used to transmit the electrical current from
the stimulator to the nerve. The electrodes reduce the resistance to theelectric impulse. In
clinical practice, the skin electrodes used are usually disposable, and use silver/silver
chloride as the conducting electrolyte solution. They should be firmly applied to clean
dry skin. When a supramaximal response cannot be obtained with skin electrodes, needle
electrodes may be placed subcutaneously in closeproximity to, butnever in, the nerve.
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SITES OF STIMULATION
Essentially any superficial peripheral nerve may be stimulated. The ulnar nerve is
the most popular, and the response of the adductor pollicis muscle (thumb) is monitored.
This site is well suited for visual, tactile, and mechanomyographic assessments. In addi-
tion, this muscle is on the side of the arm opposite the site of stimulation; therefore, there
is little chance ofdirect muscle stimulation, suggesting an incomplete block. To stimulate
the ulnar nerve, one electrode is placed on the radial side of the flexor carpi ulnaris ten-
don about 1 cm proximal to the wrist skin crease. The other electrode may be placed 3-4
cm proximal to the distal electrode, or over the ulnar groove on the medial epicondyle of
the elbow. When the latter placement is used, the flexor carpi ulnaris muscle may be
stimulated and result in augmented thumb adduction. Polarity of the electrodes is not
important when both electrodes are in close proximity to the wrist. However, ifone elec-
trode is placed over the elbow, the active (negative) electrode should be placed at the
wrist to ensure maximum stimulation ofthe ulnar nerve [74,75].
Muscle groups differ in their sensitivity to muscle relaxants [76]. The exact cause of
these differences is multifactorial and has not been fully elucidated. Proposed mecha-
nisms include different regional blood flow, differences in muscle temperature and densi-
ty of receptors, varying margins of safety at the NMJ, and differences in muscle fiber
composition. Compared to the adductor pollicis muscle, the diaphragm requires 1.5-2
times the amount ofrelaxant to achieve paralysis due to its resistance to depolarizing and
nondepolarizing agents [77, 78]. After abolus dose ofrelaxant, the diaphragm and upper
airway muscles achieve onset and recovery of block quicker than peripheral muscles,
possibly because of their higher blood flow [79, 80, 81, 82]. Differences in sensitivity to
relaxants and in onset times have clinical implications when peripheral sites are moni-
tored. When high doses ofrelaxants are used (> 2 times theED95), the fasteronset time at
the diaphragm tends to predominate, and adequate blockade should be achieved before it
is evidenced by the adductor pollicis muscle response [81]. However, if lower doses of
relaxant are used, the lesser sensitivity of the diaphragm may predominate, and the
adductor pollicis twitch may be ablated 30-60 sec before maximal diaphragmatic relax-
ation is achieved [83].
The response ofthe orbicularis oculi muscle to facial nerve stimulation reflects more
closely the sensitivity of, and time course at, the airway musculature [80, 81, 84, 85]. The
electrodes are placed 2-3 cm posterior to the lateral border of the orbit. However, direct
muscle stimulation may occur, resulting in an enhanced response and underestimation of
the degree of blockade. In addition, the orbicularis oculi response is not readily quanti-
fied mechanographically.
CLINICAL ASSESSMENT OFNEUROMUSCULAR FUNCTION
A variety ofclinical signs have been employed to estimate the degree ofneuromus-
cular block and adequacy of reversal: patients' ability to open their eyes, protrude their
tongue, swallow, lift the head for 5 sec, or to sustain a hand grip. An initial strong con-
traction which weakens overtime is characteristic ofresidual paralysis; such patients will
be unable to sustain muscle activity, and their movements may appear "jerky." While
clinical tests of neuromuscular integrity are useful in assessing the degree of blockade,
they require patient's cooperation and cannot be performed in unconscious patients. The
adequacy of the tidal volume, vital capacity, and inspiratory pressure, as well as the pat-
tern ofrespiration, have been used as markers for neuromuscular integrity. Patients with
partial blockade may, however, have adequate ventilation and a normal tidal volume, but
their airway reflexes and ability to cough can still be impaired. In addition, perioperative
respiratory depression may be due to central blunting ofthe respiratory drive by opioids,
481Kelly andBrull: Neuromuscular monitoring
anesthetic agents, and/or low arterial CO2 levels. Residual blockade can only be con-
fimed as a cause ofrespiratory depression by demonstrating impairment ofneuromuscu-
lar transmission.
Studies have shown that the T4/T1 ratio correlates with some clinical criteria used to
assess recovery from neuromuscular block. When the T4/T1 ratio was greater than 60%,
patients achieved sustained head lift for 3 sec or more [86]. When this ratio exceeded
75%, eye opening, cough, and tongue protrusion were clinically normal. In addition, at
this T4[T1 ratio, after d-tubocurarine and N20/narcotic anesthesia, a vital capacity of
15-20 ml/kg, a negative inspiratory pressure of20-25 cm H20 and a sustained head lift
for 5 sec were present [57, 87]. Neuromuscular monitoring provides objective evidence
of the degree of block and may be used in unconscious patients. It should not replace
clinical judgment, but rather the two modes complement each other in assessment of the
status ofneuromuscular transmission.
MONITORING OF THE RESPONSETO NERVE STIMULATION
After the nerve has been stimulated using one of the patterns outlined above, the
evoked muscle response is monitored in the clinical setting using various means, either
objective orsubjective, oracombination.
SUBJECTIVE MEANS
Visual and tactile assessment
Visual and/or tactile assessment remain the most popular method ofmonitoring neu-
romuscular fade in response to TOF stimulation in clinical practice. For visual assess-
ment, the observer should be at an angle of 900 to the plane of muscle movement. For
tactile assessment, the thumb should be held in full abduction, and the observer's finger-
tips placed over the distal phalanx in the direction of movement. However, such subjec-
tive assessments will not be consistent in detecting neuromuscular fade even when per-
formed by experienced observers [13, 88, 89]. DBS, as mentioned above, has been intro-
duced in an attempt to improve non-mechanographic detection offade.
Studies ofDBS have reported more accurate detection ofneuromuscular fade, and its
usefulness in this regard is now generally accepted. Such testing may be performed with
submaximal nerve stimulation without loss of accuracy and with less patient discomfort
[90]. Recent investigations have reported that regardless ofpattern ofneurostimulation or
the current intensity delivered, there was no significant difference in the ability to detect
fade between visual and tactile means [90].
OBJECTIVE MEANS
Precise assessment of neuromuscular blockade can be quantified by mechanomyog-
raphy, electromyography, and accelerography; these measure evoked mechanical
response, electrical response, and muscle acceleration, respectively. These techniques are
much more accurate in quantifying the muscular blockade than visual or tactile assess-
ment. However, they are infrequently used in clinical anesthesia due to time constraints,
lack ofavailability, and theirexpense.
Mechanomyography
With this method, a force translation monitor is used to measure the evoked muscle
tension. The isometric contraction of the muscle (usually the adductor pollicis muscle is
selected) in response to stimulation ofits innervating nerve is translated via a force trans-
ducer into an electrical signal. The signal is recorded and quantified on a pressure moni-
tor, and the amplitude of the signal is proportional to the strength of muscle contraction.
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By measuring theT4/T1 signal ratio, thedegree offade canbeaccurately recorded.
For consistent measurement of muscle response, certain precautions should be
undertaken. The hand must be fully immobilized to reduce movement artifact, while
movement of the thumb in the force transducer unit must be unencumbered. The thumb
must always apply tension along the axis of the transducer, so that the degree of move-
ment is fully appreciated. A preload of 200-300 g should be applied to the abducted
thumb before ulnar nerve stimulation to ensure isometric contraction. The recording
monitor must be adjusted to account for the predicted response; the tension developed
after tetanic stimulation can be four times that achieved by a single twitch. A transducer
with a suitable tension range should be selected. In most clinical settings a tension range
of 0-5 kg is adequate for monitoring a non-depolarizing block, but tetanus at the
unblocked NMJ generates a force of7.1-22.0 kg [41] which can overload some transduc-
ers [91].
Electromyography
EMG is the process of recording the electrical activity of a muscle. The signal
obtained depends on the location of the recording electrodes relative to the muscle.
Usually one electrode is placed over the midportion of the muscle (close to the neuro-
muscularjunction) and the other isplaced over the tendon ofinsertion. The third (neutral)
electrode's placement is variable. Such positioning gives the most consistent EMG sig-
nals [92]. After stimulation of the innervating nerve, electrical activity of the muscle is
inversely proportional to the degree ofblock at the NMJ. The compound action potential
evoked is recorded in the EMG: the amplitude of the compound action potential repre-
sents the sum ofthe amplitudes of the individual muscle fibers activated by the stimulus.
The time between application of the stimulus and the initial deflection of the evoked
response is known as the latency period. It represents the nerve conduction time and the
time needed for neuromuscular transmission (muscle contraction is notrequired forEMG
recordings). The duration and shape of the compound action potential depends upon the
distance from the stimulating electrode to the recording device. MostEMG devices com-
pute the area under the EMG curve, as it is a better representation of overall muscular
activity. This area is then represented numerically.
When the EMG signal is recorded from the thenar eminence, studies have shown a
good correlation between the EMG and the adductor pollicis force transducer. However,
movement artifact at this monitoring site may make the EMG recording unreliable. The
hypothenar muscles are usually used for electromyography as a result, but these muscles
are less sensitive than the adductor pollicis to non-depolarizing relaxants (as measured by
the force transducer) [93, 94, 95]. TheEMG electrodes can beplaced over the first dorsal
interosseous space; in this location, the EMG response correlates well with adductorpol-
licis force transduction.
The differences between EMG and mechanomyography may be due to the sensitivity
of the latter to factors affecting muscle contraction (e.g., mechanical). The EMG, on the
other hand, is influenced by those factors involved in nerve conduction and neuromuscu-
lar transmission but is relatively independent ofmechanical events. Therefore, the factors
influencing excitation-contraction coupling (e.g., dantrolene) will not alter the EMG, but
will modify the mechanomyograph.
The advantages of the EMG over mechanomyography are its accuracy and reliabili-
ty, the fact that itis less bulky and time consuming than a force transducer, and that it can
be used to monitor a larger numberofsites than the latter. Itis, however, moreexpensive,
and electrical diathermy produces artifact. To date, EMG monitors can record the
response to single twitch and train-of-four stimulation, but do not monitor double burst
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stimulation, tetanus or thepost-tetanic twitch count.
Accelerography
The principle of accelerography is based on Newton's Law that force equals mass
times acceleration. If mass is constant, force is then directly proportional to acceleration.
Thus, the acceleration of the thumb after ulnar nerve stimulation is directly proportional
to the evoked force ofcontraction. A thin transducer (piezoelectric wafer) is attached to
the thumb. Whenever the thumb moves, a voltage is generated, its height is proportional
to the degree ofangular acceleration. The signal is amplified and displayed on a monitor
screen.
Accelerography yields comparable results to mechanomyographic TOF monitoring
at varying current amplitudes [55, 96, 97, 98]. Accelerometers are less bulky and easier
to use than force transducers, and because they measure isotonic contraction, they do not
require a preload. Results may be altered by thumb movement or failure of the thumb to
return to its baseline position after a contraction, and this may account for aT4/T1 greater
than 1.0 in the unblocked state [55]. Any impedance offree thumb movement will reduce
the accuracy of the accelerometer. While the future role ofaccelerography in anesthesia
looks promising, further studies are necessary to fully evaluate its usefulness in the clini-
cal setting.
CLINICAL APPLICATIONS AND RISKS OF
NEUROMUSCULAR MONITORING
Recent studies have highlighted the wide variability in onset and recovery times with
various relaxant regimens [2, 3]. The incidence of "residual curarization" when clinical
means of assessment are used is unacceptably high; infusion techniques with both depo-
larizing and non-depolarizing agents are notoriously difficult to titrate accurately; the
onset of phase 2 block following succinylcholine requires the use of a nerve stimulator
for its diagnosis. The newer non-depolarizing agents with short half lives (especially
mivacurium) may have such rapid offset that monitoring is needed to guide intraoperative
dosing regimens. Patient response is even more difficult to predict accurately in certain
disease states: myesthesia gravis, Eaton-Lambert Syndrome, hypothermia and
hypokalemia, among others [4, 5, 6, 99]. The pharmacokinetic parameters of relaxants
are altered in the elderly, those with renal or hepatic impairment and patients with atypi-
cal or reduced pseudocholinesterase levels [7, 100, 101]. Drug interactions may affect the
extent of neuromuscular block induction agents, while inhalational anesthetics, nitrous
oxide, succinylcholine, local anesthetics, anti-arrhythmics, aminoglycosides and calcium
channel blockers can modify the response to both relaxants and reversal agents [8,
102-115]. Given the wide variation in patient response to a dose of muscle relaxant and
the possible alteration in the pharmacodynamic and pharmacokinetic profile, it seems
prudent to monitor neuromuscular function whenever muscle relaxants areemployed.
SUMMARY
Muscle relaxants play a key role in modern anesthetic practice. Both depolarizing
and non-depolarizing agents exhibit wide pharmacodynamic variability, which makes
their effects unpredictable. Furthermore, the lone clinical assessment of intraoperative
block or adequacy of reversal is unreliable. Nerve stimulators allow assessment of the
response of the neuromuscular unit to various patterns of stimulation and complement
clinical assessment. The evoked response is proportional to the extent of neuromuscular
block, and can be quantified by visual and/or tactile means or by objective means, since
the former methods may give misleading results. It is hoped that greater understanding
and wider application of neuromuscular monitoring techniques perioperatively will
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reduce patient morbidity and improve standards ofanesthetic care.
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